SUBSCRIBE
SUBSCRIBE

Gilead Sciences, Inc.

NEWS
Analysts Not Sold On Medivation’s Xtandi as Breast Cancer Drug
BioMidwest
Abstracts For Merck & Co., Gilead And AbbVie Look Promising, Says ISI
October 1, 2014
 · 
2 min read
Job Trends
Gilead Sciences, Inc. Will Employ 500 People At New SoCal Campus
September 30, 2014
 · 
2 min read
Biotech Bay
Gilead Sciences, Inc. Looks To Erase Bristol-Myers Squibb Company’s Early Hep C Lead
September 30, 2014
 · 
1 min read
Analysts Not Sold On Medivation’s Xtandi as Breast Cancer Drug
Biotech Bay
Gilead Sciences, Inc.'s Harvoni Will Fast Track: Analyst
September 26, 2014
 · 
1 min read
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Biotech Bay
This Little Switch Could Make Gilead Sciences, Inc. Stock Billions
September 26, 2014
 · 
1 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Gilead Sciences, Inc.'s Single Tablet HIV Regimen Meets Goals In Two Phase 3 Studies
September 24, 2014
 · 
2 min read
Analysts Not Sold On Medivation’s Xtandi as Breast Cancer Drug
Biotech Bay
EU Approval Of Gilead Sciences, Inc.'s Zydelig Nothing But Good News, Says Analyst
September 19, 2014
 · 
1 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Pharm Country
60 Percent Of New York’s Hep C Patients Will Get Gilead Sciences, Inc.'s Sovaldi
September 19, 2014
 · 
2 min read
Analysts Not Sold On Medivation’s Xtandi as Breast Cancer Drug
Biotech Bay
Analyst: Gilead Sciences, Inc. Still A Buy After Cancer Drug Fail
September 17, 2014
 · 
1 min read
Load More
  • 2025 BPTW Badge - RBG.png
  • 2024 Best Places to Work
  • 2023 Best Places to Work
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Business
Gilead Sciences, Inc. Execs Bag Pay Hikes, $8 Million In Bonuses
January 31, 2014
 · 
1 min read
Business
Gilead Sciences, Inc. To Release Fourth Quarter And Year End 2013 Financial Results On Tuesday, February 4, 2014
January 29, 2014
 · 
1 min read
Biotech Bay
Gilead Sciences, Inc.'s $84,000 Hepatitis C Drug Sets Off Payer Revolt
January 28, 2014
 · 
1 min read
Business
Gilead Sciences, Inc. Announces Executive Promotions
January 28, 2014
 · 
1 min read
Biotech Bay
Europe Approves Gilead Sciences, Inc.'s Hot, New Hepatitis C Pill
January 17, 2014
 · 
6 min read
BioCapital
AHF: Gilead Sciences, Inc. Asks SEC To Block CEO Pay Resolution
January 15, 2014
 · 
1 min read
Policy
Bristol-Myers Squibb Company Ties Hepatitis C Success To Rival Gilead Sciences, Inc.'s Pill
January 15, 2014
 · 
1 min read
Policy
FDA Accepts New Drug Application For Gilead Sciences, Inc.'s Idelalisib for the Treatment of Refractory Indolent Non-Hodgkin’s Lymphoma
January 13, 2014
 · 
4 min read
Biotech Bay
Gilead Sciences, Inc. To Present At The 32nd Annual JP Morgan Healthcare Conference On Monday, January 13
January 13, 2014
 · 
1 min read
Business
First Gilead Sciences, Inc., Now Amgen Loses A Top Exec
January 10, 2014
 · 
7 min read
Load More